Taro Escapes Off-Label Use Claims For Heart Drug
A New York federal judge has tossed claims alleging Taro Pharmaceutical U.S.A. Inc. failed to prevent off-label use of its generic form of heart medication, ending a suit pushed by 67...To view the full article, register now.
Already a subscriber? Click here to view full article